Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback